Oneview Healthcare (ASX:ONE) - Chairman, Michael Kaminski
Chairman, Michael Kaminski
Source: Michael Kaminski/LinkedIn
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Oneview Healthcare (ONE) signs a five-year contract with Arizona-based Kingman Regional Medical Centre (KRMC)
  • Oneview will deploy its cloud-based Care Experience Platform (CXP) to the medical centre to give patients a “next-level care experience” while increasing efficiency for staff
  • The US$2.4 million (A$3.2 million) contract also includes integration with Meditech’s Electronic Health Records software and Caregility’s iConsult solution for virtual visits and virtual consults
  • Company shares closed up 6.98 per cent to trade at 46 cents apiece

Oneview Healthcare (ONE) has signed a five-year contract with Kingman Regional Medical Centre (KRMC).

KRMC is currently the largest healthcare provider in northwest Arizona and has a 235-bed multi-campus healthcare system with more than 1900 employees, 270 health professionals and 150 volunteers.

The US$2.4 million (A$3.2 million) contract will see Oneview’s cloud-based Care Experience Platform (CXP) be deployed in the KRMC healthcare system.

The CXP enables healthcare organisations to adopt technology for to cater for a variety of patient needs which helps to reduce non-clinical demands on care teams, and optimises clinical and operational efficiency.

Kingman will deploy Oneview’s latest Android hardware in patient rooms, as well as Samsung tablets running the enhanced Digital Door Sign product at the patient door.

The contract also includes integration with the Meditech Electronic Health Records (EHR) software as well as Caregility’s iConsult solution for virtual rounding, virtual visitation and virtual consults.

Kingman CEO Will McConnell was pleased to have signed this contract.

“Being able to deliver a next-level care experience for our patients while increasing efficiency for our staff by the end of the year is a game changer,” he said. “We are thrilled to leverage this new partnership so we can finally put our vision into reality.”

The CXP system is expected to begin deployment in December.

Company shares closed up 6.98 per cent to trade at 46 cents apiece.

ONE by the numbers
More From The Market Online
The Market Online Video

Listen: From the Wire – Paradigm Biopharma CEO and Founder Paul Rennie

From The Wire: Senior markets reporter Jonathon Davidson sat down with Paradigm Biopharmaceuticals chief executive officer…
Lung imaging concept

Biotech lung imaging darling 4DX Medical back at $2.20/sh on Miami U contract

4DX Medical has seen its price jump back to $2.20/sh, as its next-gen lung imaging scan…
Chuffed bloke

Race Oncology’s placement-at-a-premium rewarded as shares jump +8%

Race Oncology has completed its recent A$3.2M placement – something that shareholders on the HotCopper forums…

Effective as an IV drug, a gel, and now an inhaler – Recce’s R327 can’t stop winning

Recce flagship antibacertial and anti-infective drug R327 has in a model that shows the drug could…